• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

癌症患者心血管疾病的患病率及临床危险因素:一项横断面研究

Prevalence and clinical risk factors of cardiovascular disease in patients with cancer: a cross-sectional study.

作者信息

Jiang Cheng, Chen Yun-Xiang, Geng Qing-Shan, Liu An-Bang

机构信息

Department of Geriatrics, The Second Clinical Medical College of Jinan University, The First Affiliated Hospital of Southern University of Science and Technology, Shenzhen People's Hospital, Shenzhen, 518020, Guangdong, China.

Department of Cardiology, Shenzhen Cardiovascular Minimally Invasive Medical Engineering Technology Research and Development Center, Shenzhen People's Hospital (The Second Clinical Medical College, Jinan University; The First Affiliated Hospital, Southern University of Science and Technology), Luohu District, No.1017, Dongmen North Road, Shenzhen, Guangdong, 518020, China.

出版信息

BMC Cardiovasc Disord. 2025 Jul 19;25(1):526. doi: 10.1186/s12872-025-04976-2.

DOI:10.1186/s12872-025-04976-2
PMID:40684099
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12275422/
Abstract

OBJECTIVE

This study aimed to investigate the prevalence of common cardiovascular diseases (CVDs) and their clinical risk factors among patients with cancer and to offer clinical evidence to help manage CVD within this population.

METHODS

Patients with cancer who were aged ≥ 20 years were selected from the National Health and Nutrition Examination Survey (NHANES) 2015-2020. The prevalence of CVD and its components was analyzed using weighted analysis to obtain standardized prevalence. Subgroup analyses for gender and age were also performed. Lastly, the clinical risk factors for CVD in patients with cancer were identified by conducting multivariable logistic regression.

RESULTS

A total of 1729 individuals diagnosed with cancer were included, among which 432 had CVD. Weighted analysis further revealed that 21.21% (95%CI: 17.55-24.86) of the patients with cancer had CVD. Moreover, CVD prevalence was 25.12% in males and 18.30% in females (P = 0.01), while it was 26.93% in the age group of ≥ 65 years and 14.58% in the < 65 years age group (P < 0.001). In terms of CVD components, angina pectoris was diagnosed in 4.51% of the patients, myocardial infarction in 8.56%, coronary heart disease in 10.09%, heart failure in 5.08%, and stroke in 7.57%. Multivariable logistic regression analysis indicated that older age (OR = 1.02, 95% CI: 1.01-1.03), smoking history (OR = 1.56, 95% CI: 1.02-2.39 for former smoking and OR = 2.82, 95% CI: 1.59-5.01 for current smoking), hypertension (OR = 2.78, 95% CI: 1.81-4.28), diabetes (OR = 2.04, 95% CI: 1.47-2.84), chronic kidney disease (CKD, OR = 1.73, 95% CI: 1.28-2.34), and antineoplastic or other treatments (OR = 4.83, 95% CI: 2.15-10.85) were statistically significant independent risk factors for CVD in patients with cancer.

CONCLUSIONS

Patients with cancer have a weighted CVD prevalence of 21.21%, with male patients and those ≥ 65 years demonstrating a higher prevalence of CVD. Independent clinical risk factors for CVD in patients with cancer comprise age, smoking history, hypertension, diabetes, CKD, and antineoplastic or other treatments.

摘要

目的

本研究旨在调查癌症患者中常见心血管疾病(CVD)的患病率及其临床风险因素,为该人群中CVD的管理提供临床依据。

方法

从2015 - 2020年国家健康与营养检查调查(NHANES)中选取年龄≥20岁的癌症患者。采用加权分析来分析CVD及其组成部分的患病率,以获得标准化患病率。还进行了性别和年龄的亚组分析。最后,通过多变量逻辑回归确定癌症患者中CVD的临床风险因素。

结果

共纳入1729例确诊癌症的个体,其中432例患有CVD。加权分析进一步显示,21.21%(95%CI:17.55 - 24.86)的癌症患者患有CVD。此外,男性CVD患病率为25.12%,女性为18.30%(P = 0.01);≥65岁年龄组CVD患病率为26.93%,<65岁年龄组为14.58%(P < 0.001)。在CVD组成方面,4.51%的患者被诊断为心绞痛,8.56%为心肌梗死,10.09%为冠心病,5.08%为心力衰竭,7.57%为中风。多变量逻辑回归分析表明,年龄较大(OR = 1.02,95%CI:1.01 - 1.03)、吸烟史(既往吸烟OR = 1.56,95%CI:1.02 - 2.39;当前吸烟OR = 2.82,95%CI:1.59 - 5.01)、高血压(OR = 2.78,95%CI:1.81 - 4.28)、糖尿病(OR = 2.04,95%CI:1.47 -

2.84)、慢性肾脏病(CKD,OR = 1.73,95%CI:1.28 - 2.34)以及抗肿瘤或其他治疗(OR = 4.83,95%CI:2.15 - 10.85)是癌症患者发生CVD的具有统计学意义的独立风险因素。

结论

癌症患者的加权CVD患病率为21.21%,男性患者和≥65岁患者的CVD患病率较高。癌症患者发生CVD的独立临床风险因素包括年龄、吸烟史、高血压、糖尿病、CKD以及抗肿瘤或其他治疗。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c7ea/12275422/f991d9b2b5d2/12872_2025_4976_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c7ea/12275422/5f9d754dba35/12872_2025_4976_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c7ea/12275422/f991d9b2b5d2/12872_2025_4976_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c7ea/12275422/5f9d754dba35/12872_2025_4976_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c7ea/12275422/f991d9b2b5d2/12872_2025_4976_Fig2_HTML.jpg

相似文献

1
Prevalence and clinical risk factors of cardiovascular disease in patients with cancer: a cross-sectional study.癌症患者心血管疾病的患病率及临床危险因素:一项横断面研究
BMC Cardiovasc Disord. 2025 Jul 19;25(1):526. doi: 10.1186/s12872-025-04976-2.
2
Cardiovascular Disease Risk Estimates in the US CKD Population Using the PREVENT Equation.使用PREVENT方程对美国慢性肾脏病患者群体进行心血管疾病风险评估。
Am J Kidney Dis. 2025 Mar 5. doi: 10.1053/j.ajkd.2025.01.012.
3
Smoking cessation for secondary prevention of cardiovascular disease.戒烟对心血管疾病二级预防的作用。
Cochrane Database Syst Rev. 2022 Aug 8;8(8):CD014936. doi: 10.1002/14651858.CD014936.pub2.
4
Association Between Comorbidity Clusters and Mortality in Patients With Cancer: Predictive Modeling Using Machine Learning Approaches of Data From the United States and Hong Kong.癌症患者共病集群与死亡率之间的关联:使用来自美国和香港的数据的机器学习方法进行预测建模
JMIR Cancer. 2025 Jul 16;11:e71937. doi: 10.2196/71937.
5
The relationship between flavonols intake and stroke in the elderly: a cross-sectional study from NHANES (2007-2010 and 2017-2018).老年人黄酮醇摄入量与中风之间的关系:一项来自美国国家健康与营养检查调查(2007 - 2010年和2017 - 2018年)的横断面研究
J Stroke Cerebrovasc Dis. 2025 Aug;34(8):108373. doi: 10.1016/j.jstrokecerebrovasdis.2025.108373. Epub 2025 Jun 7.
6
The Association of Blood Cobalt Levels with Cardiovascular and Chronic Kidney Diseases: Mediating Role of Inflammatory Indicators (SII, NLR, PLR, NMLR, and LMR).血钴水平与心血管疾病和慢性肾脏病的关联:炎症指标(全身免疫炎症指数、中性粒细胞与淋巴细胞比值、血小板与淋巴细胞比值、中性粒细胞与单核细胞比值及淋巴细胞与单核细胞比值)的中介作用
Cardiovasc Toxicol. 2025 Jun 18. doi: 10.1007/s12012-025-10018-2.
7
Cardiovascular disease risk and its determinants among hypertensive patients in Eastern Ethiopia: an institution-based cross-sectional study.埃塞俄比亚东部高血压患者的心血管疾病风险及其决定因素:一项基于机构的横断面研究。
BMJ Open. 2025 Jul 16;15(7):e102928. doi: 10.1136/bmjopen-2025-102928.
8
Prevalence of cardiovascular disease among Bangladeshi adult population: a systematic review and meta-analysis of the studies.孟加拉国成年人群中心血管疾病的患病率:一项对相关研究的系统评价和荟萃分析
Vasc Health Risk Manag. 2018 Aug 21;14:165-181. doi: 10.2147/VHRM.S166111. eCollection 2018.
9
Dietary Approaches to Stop Hypertension (DASH) for the primary and secondary prevention of cardiovascular diseases.用于心血管疾病一级和二级预防的饮食预防高血压(DASH)方案。
Cochrane Database Syst Rev. 2025 May 6;5(5):CD013729. doi: 10.1002/14651858.CD013729.pub2.
10
Surveillance for Violent Deaths - National Violent Death Reporting System, 50 States, the District of Columbia, and Puerto Rico, 2022.暴力死亡监测——2022年全国暴力死亡报告系统,50个州、哥伦比亚特区和波多黎各
MMWR Surveill Summ. 2025 Jun 12;74(5):1-42. doi: 10.15585/mmwr.ss7405a1.

本文引用的文献

1
Atherosclerotic Cardiovascular Disease in Cancer Survivors: Current Evidence, Risk Prediction, Prevention, and Management.癌症幸存者的动脉粥样硬化性心血管疾病:当前证据、风险预测、预防与管理
J Lipid Atheroscler. 2025 Jan;14(1):30-39. doi: 10.12997/jla.2025.14.1.30. Epub 2024 Jul 19.
2
Association of cardiovascular disease on cancer: observational and mendelian randomization analyses.心血管疾病与癌症的关联:观察性和孟德尔随机化分析
Sci Rep. 2024 Dec 24;14(1):28465. doi: 10.1038/s41598-024-78787-4.
3
Atherosclerosis and the Bidirectional Relationship between Cancer and Cardiovascular Disease: From Bench to Bedside-Part 1.
动脉粥样硬化以及癌症与心血管疾病之间的双向关系:从 bench 到 bedside - 第 1 部分。 注:“bench”直译为“长凳”,这里结合语境意译为基础研究(bench research);“bedside”直译为“床边”,这里结合语境意译为临床应用(bedside application) ,表示从基础研究到临床应用的过程 。完整准确的译文可以是:动脉粥样硬化以及癌症与心血管疾病之间的双向关系:从基础研究到临床应用 - 第 1 部分 。 但严格按照你的要求,不添加其他任何解释或说明,就是上述译文 。
Int J Mol Sci. 2024 Apr 11;25(8):4232. doi: 10.3390/ijms25084232.
4
Association of Chronic Kidney Disease with Cardiovascular Disease in Cancer Patients: A Cross-Sectional Study.癌症患者慢性肾脏病与心血管疾病的相关性:一项横断面研究。
Cardiorenal Med. 2023;13(1):344-353. doi: 10.1159/000534182. Epub 2023 Oct 14.
5
Cancer survivorship at heart: a multidisciplinary cardio-oncology roadmap for healthcare professionals.心系癌症幸存者:面向医疗专业人员的多学科心脏肿瘤学路线图
Front Cardiovasc Med. 2023 Sep 15;10:1223660. doi: 10.3389/fcvm.2023.1223660. eCollection 2023.
6
A cross-sectional study exploring the relationship between the dietary inflammatory index and hyperlipidemia based on the National Health and Nutrition Examination Survey (2005-2018).基于 2005-2018 年全国健康与营养调查的横断面研究,探讨饮食炎症指数与高血脂症之间的关系。
Lipids Health Dis. 2023 Aug 31;22(1):140. doi: 10.1186/s12944-023-01908-x.
7
Prevalence of primary and secondary hypertension among hospitalized patients with cancer in the United States.美国癌症住院患者中原发性和继发性高血压的患病率。
Chronic Illn. 2025 Mar;21(1):42-55. doi: 10.1177/17423953231196613. Epub 2023 Aug 22.
8
Association between composite dietary antioxidant index and hypertension: insights from NHANES.复合膳食抗氧化指数与高血压的关联:来自 NHANES 的见解。
Clin Exp Hypertens. 2023 Dec 31;45(1):2233712. doi: 10.1080/10641963.2023.2233712.
9
C-Reactive Protein Levels and Risk of Cardiovascular Diseases: A Two-Sample Bidirectional Mendelian Randomization Study.C 反应蛋白水平与心血管疾病风险:两样本双向 Mendelian 随机研究。
Int J Mol Sci. 2023 May 23;24(11):9129. doi: 10.3390/ijms24119129.
10
Coronary atherosclerosis and chemotherapy: From bench to bedside.冠状动脉粥样硬化与化疗:从实验台到病床旁
Front Cardiovasc Med. 2023 Jan 19;10:1118002. doi: 10.3389/fcvm.2023.1118002. eCollection 2023.